JAMA study investigates whether physical or behavioral healthcare needs are associated with the risk of underinsurance across household income levels.
In a recently published study by the JAMA Network, researchers aimed to discover the prevalence of underinsurance among children with special health care needs (CSHCN) in the United States and assess variations based on the complexity of medical conditions and household income levels. In most cases, underinsured children are associated with lower reported quality of care, forgone care, and unmet health needs. Despite a record number of children being insured in the present day, the study credits this as coinciding with a rise in the prevalence of pediatric underinsurance.1
Conducted from 2016 to 2021, the study included 218,621 children aged 0 to 17 years that weren’t institutions. Findings included:
The issue of underinsurance goes beyond children with special health care needs. According to a Fior Reports article written by Becca Roberts, the number of uninsured people in the US remains significantly high. Citing a Commonwealth Fund report released in 2023, Roberts points out that 43% of working-age adults were underinsured in 2022, including the uninsured, those that had a gap in coverage, or those with plans that didn’t provide sufficient access to healthcare. She further explains that many people who technically have health insurance still incur very high out-of-pocket costs, including for prescription medications.2
“So, tens of millions of Americans find themselves in a precarious situation all year round. The insecurity of a healthcare system in which patchy care is so widespread means that too many people have the proverbial sword of Damocles hanging over their heads,” said Roberts. “Nearly one in five American households has medical debt, meaning they were unable to pay a medical bill at the time of treatment. For households with medical debt, the average amount owed is about $2,000. Approximately twice as many households without adequate insurance coverage have medical debt as households with insurance coverage. And according to a recent study published in the American Journal of Public Health, about 530,000 people report going bankrupt every year because of medical bills.”
The JAMA study didn’t come without limitations. First, its categorization reflected the health consequences and medical complexity of a child’s condition rather than their diagnosis. Second, measures of health insurance adequacy were based on the perceptions of parents rather than objective characteristics.1
“In this cross-sectional study, we found that during a period of rising out-of-pocket costs for many families enrolled in commercial insurance, the likelihood of underinsurance among CSHCN increased with the severity of children’s health care needs,” concluded the study authors.” Underinsurance was more prevalent among CSHCN with complex physical conditions and limitations—particularly so for middle-income households—as well as among children with mental or behavioral conditions and limitations who have unique and challenging health care needs. As health care and insurance costs continue to rise, ongoing evaluation will be necessary so that state and federal health authorities can modify public health insurance program design and eligibility to meet the needs of CSHCN best.”
References
1. Underinsurance Among Children With Special Health Care Needs in the United States. JAMA Network. December 26, 2023. Accessed January 3, 2023. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2813141
2. Far Too Many People Are Underinsured In The US Healthcare System. Fior Reports. January 1, 2024. Accessed January 3, 2024. https://fiorreports.com/far-too-many-people-are-underinsured-in-the-us-healthcare-system/
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine
November 14th 2024Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Delivery and Disruption: Navigating a Changing Care Terrain
September 16th 2024The diversification of site-of-care delivery models is accelerating rapidly, creating new go-to-market implications for drug manufacturers—but also new opportunities to drive more fundamental innovation in engagement and access strategies.